NDC 70709-013

SAJAZIR

Icatibant

SAJAZIR is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Cycle Pharmaceuticals Ltd-uk. The primary component is Icatibant Acetate.

Product ID70709-013_329a6e8e-da19-491a-acbc-3afd6e40bc1c
NDC70709-013
Product TypeHuman Prescription Drug
Proprietary NameSAJAZIR
Generic NameIcatibant
Dosage FormInjection
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2021-06-03
Marketing CategoryANDA /
Application NumberANDA212446
Labeler NameCycle Pharmaceuticals Ltd-Uk
Substance NameICATIBANT ACETATE
Active Ingredient Strength30 mg/3mL
Pharm ClassesBradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70709-013-01

1 SYRINGE, GLASS in 1 CARTON (70709-013-01) > 3 mL in 1 SYRINGE, GLASS
Marketing Start Date2021-06-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "SAJAZIR" or generic name "Icatibant"

NDCBrand NameGeneric Name
70709-013SAJAZIRICATIBANT
0093-3066IcatibantIcatibant
24201-207Icatibanticatibant
54092-135IcatibantIcatibant
63323-574IcatibantIcatibant
69097-664ICATIBANTICATIBANT
71225-114IcatibantIcatibant

Trademark Results [SAJAZIR]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SAJAZIR
SAJAZIR
90461564 not registered Live/Pending
Cycle Pharmaceuticals Ltd.
2021-01-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.